Results 251 to 260 of about 1,666,160 (306)

Streamlining IRB review of AI human subjects research (AIHSR): the three-stage framework. [PDF]

Front Syst Biol
Eto T, Miller H, Vidal D, Lifson M.
europepmc   +1 more source

Assessing Individual Intellectual Output in Scientific Research: Mexico’s National System for Evaluating Scholars Performance in the Humanities and the Behavioral Sciences

, 2016
Eugenio Frixione, Lourdes Ruiz-Zamarripa, Gerardo Hernández   +2 more
openalex   +2 more sources

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha, Bishwas Mandal, Vishal Mandal, Asis Shrestha, Amir Babu Shrestha   +4 more
wiley   +1 more source

Patient and public involvement, engagement, and participation in practice: co-production of a creative health approach and theory of change through the ReCITE consortium-building project in Liverpool. [PDF]

Res Involv Engagem
Holford D, Hemingway C, Ozano K, Ismail A, Glover S, Maclennan S, Lewis D, Morris M, Heneghan M, Jolly A, Ekpo VI, Essale N, Madroumi R, ReCITE Consortium, Tolhurst R, Taegtmeyer M.   +15 more
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Patient perspective on large-language model responses to questions about Moyamoya. [PDF]

Acta Neurochir (Wien)
Ruppert-Gomez MR, Choi JH, Staffa SJ, Holste K, Xu J, Stratton C, Kocher SD, Smith ER, See AP.   +8 more
europepmc   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte, Lucy Norcliffe‐Kaufmann, Maria Luisa Cotrina, Zenith Khan, Kaia Dalamo, Patricio Millar Vernetti, Matthew Lawless, Elisabetta Morini, Monica Salani, Marla Weetall, Jana Narasimhan, Agostino G. Rocha, Susan A. Slaugenhaupt, Horacio Kaufmann   +13 more
wiley   +1 more source

Audience-Specific Health Communication: Mixed Methods Evaluation of the Maria Ciência AI-Assisted Knowledge Translation Tool. [PDF]

JMIR Infodemiology
Araújo-Pereira M, Villalva-Serra K, Pires-Ramos G, Sousa-Peres B, Conceição-Oliveira JN, Maiche SD, Silva RRDC, Andrade BB.   +7 more
europepmc   +1 more source

Research on output power modeling of all-electric marine diesel generator set based on data-driven

Longhai Xiao, Wanneng Yu, Haibin Wang, Yao Chen   +3 more
openalex   +1 more source